La-Medicca (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-12-2024
- Paid Up Capital ₹ 1.00 M
as on 04-12-2024
- Company Age 36 Year, 8 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 1.12 Cr
as on 04-12-2024
- Revenue 10.47%
(FY 2017)
- Profit 2.43%
(FY 2017)
- Ebitda 137.98%
(FY 2017)
- Net Worth 9.99%
(FY 2017)
- Total Assets -6.86%
(FY 2017)
About La-Medicca (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Cherry Jain and Amit Jain serve as directors at the Company.
- CIN/LLPIN
U74899DL1988PTC031275
- Company No.
031275
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 1988
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does La-Medicca (India) Private Limited offer?
La-Medicca (India) Private Limited offers a wide range of products and services, including Common Disease Medicines, Cough Syrup, Dumbbell, Weight Plate & Accessories, Yoga Accessories, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Medical Pillow, Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Herbal Capsules.
Who are the key members and board of directors at La-Medicca (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Jain  | Director | 01-Apr-2002 | Current |
| Cherry Jain | Additional Director | Current |
Financial Performance of La-Medicca (India).
La-Medicca (India) Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 10.47% increase. The company also saw a slight improvement in profitability, with a 2.43% increase in profit. The company's net worth moved up by a moderate rise of 9.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of La-Medicca (India)?
In 2017, La-Medicca (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indnian Overseas Bank Creation Date: 30 May 2016 | ₹3.90 M | Satisfied |
Indian Overseas Bank Creation Date: 14 Feb 2011 | ₹2.50 M | Satisfied |
Indian Overseas Bank Creation Date: 30 Jul 2008 | ₹0.60 M | Satisfied |
How Many Employees Work at La-Medicca (India)?
Unlock and access historical data on people associated with La-Medicca (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of La-Medicca (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped La-Medicca (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
